Company Performance Metrics
- Mark Ross: Co-Founder & Head of Product
- Catherine Winckler: Founder and CEO
MindfulGarden is the first clinically validated interactive behaviour management platform for delirium, an acute change in the brain that affects over 60% of patients in the ICU, with high human costs and a system burden of $92B annually in North America
Built in the UNITY game engine, MindfulGarden’s voice, motion, and vital sign sensors capture
patient agitation levels, translating anonymous data into calming nature-based visualizations and sounds on-screen that level up and down, matching intensity of behaviours. In the Company’s foundational clinical study NCT04652622, MindfulGarden proved to quickly de-escalate adverse behaviours as measured by the Richmond Agitation Scale Score (RASS), and reduce PRN (as needed) psychotropic drug administration by 25.7%.
